KUALA LUMPUR: Sime Darby Oils (SDO) and Universiti Kebangsaan Malaysia (UKM) will carry out clinical trials to find out if the palm oil derived Tocotrienols can be used in treating non-alcoholic fatty liver disease (NAFLD).
In a joint statement issued on Tuesday, they said this is the world’s first comprehensive clinical trial whether Tocotrienols, an antioxidant in the vitamin E family, could be used in NAFLD treatment.
They expect to see preliminary results within six months from the start of the clinical trial this month and a full publication of the findings in 2021.
...